Spots Global Cancer Trial Database for Combination of Cryosurgery and NK Immunotherapy for Advanced Non-Small Cell Lung Cancer

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Combination of Cryosurgery and NK Immunotherapy for Advanced Non-Small Cell Lung Cancer

Official Title:

Study ID: NCT02843815

Conditions

Non-small Cell Lung Cancer Metastatic

Interventions

Cryosurgery

NK Immunotherapy

Study Description

Brief Summary: The aim of this study is the safety and efficacy of cryosurgery plus NK immunotherapy to advanced NSCLC.

Detailed Description: By enrolling patients with NSCLC adapted to enrolled criteria, this study will document for the first time the safety and the short and long term efficacy of the combined therapy using cryosurgery and nature killer (NK) cells for NSCLC. The safety will be evaluated by statistics of adverse reactions. The efficacy will be evaluated according to local relief degree, progress free survival (PFS) and overall survival (OS).